Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
2.8K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

39.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing the translation gap in SCT donor selection.

Frontiers in immunology·2026
Same author

How does the level of care change after proximal humeral fracture in older patients? A propensity score matching analysis.

European geriatric medicine·2026
Same author

Author Correction: Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.

Nature genetics·2026
Same author

Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.

Nature genetics·2026
Same author

Pathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype.

Nature communications·2026
Same author

The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland.

Pediatric blood & cancer·2026

Related Experiment Video

Updated: Apr 3, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.8K

MYCN Amplification in RB1-Inactivated Retinoblastoma: Association With High-Risk Features.

Kyriaki Papaioannou1, Regina Kubica2, Karen Fischhuber3

  • 1Department of Pediatrics III, University Hospital Essen, Essen, Germany.

Pediatric Blood & Cancer
|April 2, 2026
PubMed
Summary

MYCN amplification in retinoblastoma (a rare eye cancer) is linked to RB1 gene inactivation and more aggressive disease. This finding highlights MYCN amplification as a potential marker for advanced retinoblastoma.

Keywords:
biomarkerchemotherapychoroidal infiltrationglaucomaprognosisscleral invasion

More Related Videos

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.8K
Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

3.3K

Related Experiment Videos

Last Updated: Apr 3, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.8K
Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.8K
Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

3.3K

Area of Science:

  • Ophthalmology
  • Oncology
  • Genetics

Background:

  • MYCN amplification occurs in some retinoblastoma cases, with or without RB1 inactivation.
  • Retinoblastomas with MYCN amplification may represent a distinct, more aggressive subtype.

Purpose of the Study:

  • To investigate the incidence of MYCN gain/amplification in retinoblastoma.
  • To compare clinical and histopathological features between MYCN-amplified and non-amplified retinoblastomas.

Main Methods:

  • Quantitative PCR and SNP microarray analysis were used to assess MYCN copy number.
  • RB1 mutation status, clinical data, and histopathology were analyzed in 192 unilateral retinoblastoma samples.

Main Results:

  • MYCN gain/amplification was detected in 7.2% of retinoblastomas, all with RB1 inactivation.
  • MYCN-amplified retinoblastomas showed increased rates of secondary glaucoma, choroidal, and scleral invasion.
  • No significant difference in age at diagnosis was observed between groups.

Conclusions:

  • MYCN amplification in retinoblastoma is associated with RB1 inactivation.
  • MYCN amplification correlates with more advanced disease and aggressive features, suggesting a distinct clinical entity.